Video

What Should Pharmacists Advise Patients Taking Aspirin and Rivaroxaban, if Approved?

Conference|ESC Congress - European Society of Cardiology Congress

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

In this clip, Deepak Bhatt, MD, discusses how pharmacists should counsel patients taking aspirin and rivaroxaban, if approved.

Related Videos
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Related Content
Precision medicine in neurology -- Image credit: Evon J | stock.adobe.com
April 9th 2025

AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Syringe and vial labeled GLP 1 are prominently displayed, symbolizing medical advancements and treatments. background features blurred, colorful pattern, enhancing focus on medical items - Image credit: mingnimit | stock.adobe.com
April 9th 2025

Expert Q&A: Exploring the Role of GLP-1 Receptor Agonists in Diabetes Management

Kennedy Ferruggia, Assistant Editor Elaina Rosario, PharmD, CPh, BCACP, CDCES
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Child with a migraine -- Image credit: irena_geo | stock.adobe.com
April 8th 2025

AAN 2025: Fremanezumab Superior to Placebo in Reducing Monthly Migraine Days in Children and Adolescents

Gillian McGovern, Associate Editor
SGO 2025: The MRI Gap and How Race and Insurance Shape Cervical Cancer Treatment Timelines
April 8th 2025

SGO 2025: The MRI Gap and How Race and Insurance Shape Cervical Cancer Treatment Timelines

Sophie Jabban Alana Hippensteele, Lead Editor